These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Biomarkers in heart failure: are they clinically useful?]. Kempf T; Wollert KC Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752 [No Abstract] [Full Text] [Related]
24. [Effect of concomitant chronic kidney disease on the xanthine metabolism in patients with chronic heart failure]. Kolomiets MV; Bil'chenko AV Georgian Med News; 2014 Nov; (236):35-9. PubMed ID: 25541823 [TBL] [Abstract][Full Text] [Related]
25. Uric acid: role in cardiovascular disease and effects of losartan. Alderman M; Aiyer KJ Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846 [TBL] [Abstract][Full Text] [Related]
26. Uric acid as a prognostic marker in acute heart failure--new expectations from an old molecule. Doehner W; von Haehling S; Anker SD Eur J Heart Fail; 2007 May; 9(5):437-9. PubMed ID: 17433888 [No Abstract] [Full Text] [Related]
27. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Kupper N; Gidron Y; Winter J; Denollet J Psychosom Med; 2009 Nov; 71(9):973-80. PubMed ID: 19834046 [TBL] [Abstract][Full Text] [Related]
28. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure]. Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987 [TBL] [Abstract][Full Text] [Related]
29. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Doehner W; Landmesser U Semin Nephrol; 2011 Sep; 31(5):433-40. PubMed ID: 22000650 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of uric acid in patients with acute dyspnea. Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335 [TBL] [Abstract][Full Text] [Related]
34. Allopurinol as a cardiovascular drug. Kelkar A; Kuo A; Frishman WH Cardiol Rev; 2011; 19(6):265-71. PubMed ID: 21983313 [TBL] [Abstract][Full Text] [Related]
35. The ongoing search for a stratified medicine approach in heart failure. Tang WH J Am Coll Cardiol; 2008 Jun; 51(24):2310-2. PubMed ID: 18549914 [No Abstract] [Full Text] [Related]
36. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396 [TBL] [Abstract][Full Text] [Related]
37. Minimal and best linear combination of oxidative stress and antioxidant biomarkers to discriminate cardiovascular disease. Schisterman EF; Faraggi D; Browne R; Freudenheim J; Dorn J; Muti P; Armstrong D; Reiser B; Trevisan M Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):259-66. PubMed ID: 12616805 [TBL] [Abstract][Full Text] [Related]
38. Uric acid elevation in atrial fibrillation: is it simply an epiphenomenon or not? Koza Y Int J Cardiol; 2014 Jul; 174(3):869. PubMed ID: 24801089 [No Abstract] [Full Text] [Related]
39. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. Kotlyar E; Vita JA; Winter MR; Awtry EH; Siwik DA; Keaney JF; Sawyer DB; Cupples LA; Colucci WS; Sam F J Card Fail; 2006 Mar; 12(2):122-7. PubMed ID: 16520260 [TBL] [Abstract][Full Text] [Related]
40. Hyperuricaemia and congestive heart failure: causation or association? Gottlieb S Eur Heart J; 1998 Dec; 19(12):1746-7. PubMed ID: 9886713 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]